May 1st, 2021:
Cannabinoid analyses on CBD products
From May 1st 2021, GlycoMScan can provide you with high quality cannabinoid analyses, to combat the inconsistent results that are provided by different laboratories. We give the special care that cannabinoid molecules ask for to properly quantify them.
Our analytical instruments are state-of-the-art and under SLA, which means that we can guarantee you short-time to accurate and sensitive results.
When you are interested in our analyses, please contact us via info@glycomscan.com
In view of the corona crisis…
June 2nd, 2020:
During the current pandemic crisis, we still continue and work on ongoing and new projects according to our high quality standards that you are used to.
New: we offer hand sanitizer spray based on the WHO recipe. It is made from biological ingredients and suitable for children. Read more…
Towards our GLP accreditation
February 24th, 2020:
To be able to grow together with our clients to the next phase in preclinical studies, it is our ambition to have the accreditation Good Laboratory Practice (GLP) ready by this year. This data quality system comprises complete track-and-trace of all materials, Standard Operating Procedures, validation of bio-analytical methodologies like our bio-analyses, pharmacokinetics (PK) and Glycomics analyses, and the four eyes principle as cornerstone. The GLP system aims to ensure and promote safety, consistency, high quality, and reliability of chemicals in the process of non-clinical and laboratory testing.
Eurostars grant for GlycoMScan!
December 19th, 2019:
On position 40 out of 369 applicants in Europe, today we obtained a Eurostars grant in collaboration with Florabio A.Ş., PAIA Biotech GmbH and Biberach University of Applied Sciences.
GlycoMScan presented poster on the Dutch Life Science conference in Leiden Bio Science Park on November 28th, 2019
We enjoyed this great conference a lot, especially meeting several new customers and people to collaborate with!
PFAS analyses aangeboden
De Volkskrant publiceerde op 24 September j.l. dat de laboratoriumcapaciteit in Nederland niet toereikend is om snel alle grond en slib op pfas te controleren, aldus Bouwend Nederland.
Dus wees er snel bij, want op dit moment kennen wij geen wachttijden en kunnen daardoor korte doorlooptijden bieden.
NVWA accreditation
GlycoMScan obtained the official Article 17 accreditation from the NVWA with number 219393, to work with biological materials for research and diagnostics on April 16th 2019.
Interviewed by science journalists – February ’19:
“I love to get my hands dirty in the lab”.
Monique van Scherpenzeel (1981) exchanged the University for the Business world. In April 2018 she started her own company, GlycoMScan, providing mass spectrometry services to pharmaceutical companies: she performs measurements and advises on formulating research questions.
GlycoMScan exhibition on GlycoBioTec2019 in Berlin
January 28-30th 2019: GlycoMScan exhibited on conference GlycoBioTec in Berlin at the Max Planck Institute, which resulted in new customers and an European grant proposal: https://www.mpi-magdeburg.mpg.de/glycobiotec2019
First employee started
First employee started at GlycoMScan in January 2019. She is an highly experienced LC-MS research technician.
HAN Student Analytical Chemistry
HAN Student Analytical Chemistry performed successfully a research minor project.
You need to analyze small molecules?
24 September 2018: GlycoMScan B.V. presents a brand new 6125 HPLC-DAD-MSD instrument for your needs in analysis of small molecules. It is broadly applicable, e.g. for purity analysis, qualitative analyses of reaction mixtures, or to develop new chromatography methods. The instrument is equipped with a binary pump, a diode-array detector and a mass spectrometry detector for positive and negative mode. After instruction, you are welcome to use the instrument. Please feel free to contact us if you are interested!
Welcome reception & opening on June 20th:
New at Pivot Park – GlycoMScan B.V.
Recently GlycoMScan has opened their company’s doors in the van Leeuwenhoek building’s basement. GlycoMScan offers services in mass spectrometry, from screening of small molecules to absolute quantification in complex biological matrices. “As the name suggests, I am specialized in analyses of glycosylation and the building blocks thereof, the nucleotide sugars and phosphorylated sugars from intracellular metabolism,” says Monique van Scherpenzeel, GlycoMScan’s CEO. ”I chose Pivot Park because of the inspiring atmosphere of (start-up) companies in pharma and life sciences, the good quality laboratory facilities and the opportunity for me and my company to serve your R&D with my services in mass spectrometry.” Interested in learning more? Visit Monique’s ‘Welcome to Pivot Park Drinks & Labtour’ on Wednesday June 20th.
The UHPLC-QqQ arrives (May 2018)!
